$RIGL
RIGEL PHARMACEUTICALS INC

2020 Q4 Form 10-K Financial Statement

#000155837021002254 Filed on March 02, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $18.45M $18.39M $16.02M
YoY Change 19.81% -11.83% 53.94%
Cost Of Revenue $320.0K $140.0K $279.0K
YoY Change 77.78% -54.84% -10.29%
Gross Profit $17.43M $16.15M $14.70M
YoY Change 27.7% 41.58% 49.01%
Gross Profit Margin 94.48% 87.82% 91.72%
Selling, General & Admin $21.82M $17.43M $18.92M
YoY Change 19.17% -3.81% 3.9%
% of Gross Profit 125.17% 107.93% 128.75%
Research & Development $15.14M $14.60M $14.21M
YoY Change 6.25% 0.95% 7.47%
% of Gross Profit 86.85% 90.41% 96.73%
Depreciation & Amortization $210.0K $160.0K $170.0K
YoY Change 16.67% 0.0% -5.56%
% of Gross Profit 1.2% 0.99% 1.16%
Operating Expenses $36.96M $32.03M $33.13M
YoY Change 13.51% -1.7% 5.4%
Operating Profit -$19.53M -$13.78M -$17.39M
YoY Change 3.27% 14.49% -18.5%
Interest Expense -$410.0K $429.0K $353.0K
YoY Change -392.86% 5262.5% -51.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$19.24M -$14.17M -$17.58M
YoY Change 11.86% 23.36% -14.72%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$19.24M -$14.17M -$17.58M
YoY Change 11.86% 23.36% -14.7%
Net Earnings / Revenue -104.28% -77.08% -109.73%
Basic Earnings Per Share -$0.08 -$0.10
Diluted Earnings Per Share -$113.8K -$0.08 -$0.10
COMMON SHARES
Basic Shares Outstanding 169.0M 168.9M 168.6M
Diluted Shares Outstanding 169.0M 168.9M 168.6M

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.30M $72.80M $92.50M
YoY Change -41.59% -32.28% -17.7%
Cash & Equivalents $30.37M $36.57M $36.47M
Short-Term Investments $27.00M $36.20M $56.00M
Other Short-Term Assets $14.00M $10.40M $7.200M
YoY Change 47.37% 79.31% 80.0%
Inventory $1.638M $2.050M $1.684M
Prepaid Expenses
Receivables $15.97M $14.63M $11.73M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $88.98M $99.85M $113.1M
YoY Change -25.23% -20.76% -9.16%
LONG-TERM ASSETS
Property, Plant & Equipment $2.676M $2.517M $2.381M
YoY Change 23.95% -91.44% -92.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $824.0K $820.0K $653.0K
YoY Change 18.39% 17.14% -6.71%
Total Long-Term Assets $21.40M $23.21M $24.95M
YoY Change -25.1% -22.89% -21.31%
TOTAL ASSETS
Total Short-Term Assets $88.98M $99.85M $113.1M
Total Long-Term Assets $21.40M $23.21M $24.95M
Total Assets $110.4M $123.1M $138.0M
YoY Change -25.2% -21.17% -11.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.707M $2.283M $3.414M
YoY Change -10.72% -15.44% -10.16%
Accrued Expenses $3.661M $28.80M $28.10M
YoY Change 29.09% 7.46% 21.12%
Deferred Revenue $3.018M $3.069M $3.215M
YoY Change -88.07%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $40.84M $34.19M $34.76M
YoY Change -29.84% 10.3% 22.39%
LONG-TERM LIABILITIES
Long-Term Debt $19.80M $19.80M $19.80M
YoY Change 102.04% 102.04%
Other Long-Term Liabilities $5.045M $5.000M $5.000M
YoY Change -1.04% -89.22% -89.9%
Total Long-Term Liabilities $5.045M $5.000M $5.000M
YoY Change -1.04% -91.1% -89.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.84M $34.19M $34.76M
Total Long-Term Liabilities $5.045M $5.000M $5.000M
Total Liabilities $45.89M $39.19M $39.76M
YoY Change -27.52% -55.06% -48.96%
SHAREHOLDERS EQUITY
Retained Earnings -$1.306B -$1.287B -$1.273B
YoY Change 2.33%
Common Stock $1.340B $1.338B $1.336B
YoY Change 0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.03M $50.96M $63.21M
YoY Change
Total Liabilities & Shareholders Equity $110.4M $123.1M $138.0M
YoY Change -25.2% -21.17% -11.63%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$19.24M -$14.17M -$17.58M
YoY Change 11.86% 23.36% -14.7%
Depreciation, Depletion And Amortization $210.0K $160.0K $170.0K
YoY Change 16.67% 0.0% -5.56%
Cash From Operating Activities -$15.58M -$19.48M -$14.04M
YoY Change 61.45% 33.06% -15.68%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K -$200.0K $50.00K
YoY Change -19.35% -42.86% -145.45%
Acquisitions
YoY Change
Other Investing Activities $9.220M $19.72M -$5.280M
YoY Change -231.71% 39340.0% -63.71%
Cash From Investing Activities $8.710M $19.53M -$5.230M
YoY Change -214.3% -6834.48% -64.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 670.0K 50.00K 10.51M
YoY Change -4.29% -99.49% 1136.47%
NET CHANGE
Cash From Operating Activities -15.58M -19.48M -14.04M
Cash From Investing Activities 8.710M 19.53M -5.230M
Cash From Financing Activities 670.0K 50.00K 10.51M
Net Change In Cash -6.200M 100.0K -8.760M
YoY Change -62.58% -101.95% -71.26%
FREE CASH FLOW
Cash From Operating Activities -$15.58M -$19.48M -$14.04M
Capital Expenditures -$500.0K -$200.0K $50.00K
Free Cash Flow -$15.08M -$19.28M -$14.09M
YoY Change 67.0% 34.92% -14.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
529000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001034842
CY2020 dei Entity Registrant Name
EntityRegistrantName
RIGEL PHARMACEUTICALS INC
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2019 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 dei Document Type
DocumentType
10-K
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
167987850
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
169316782
CY2017Q4 rigl Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
CY2020 dei City Area Code
CityAreaCode
650
CY2020 dei Local Phone Number
LocalPhoneNumber
624-1100
CY2020 dei Security12b Title
Security12bTitle
Common Stock, par value $.001 per share
CY2020 dei Trading Symbol
TradingSymbol
RIGL
CY2019Q4 us-gaap Inventory Net
InventoryNet
1354000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14045000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9462000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
88983000
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
000-29889
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3248524
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
1180 Veterans Blvd.
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 rigl Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
308565236
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
170041848
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30373000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22521000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
26954000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
75557000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15973000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10111000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1638000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
119005000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2676000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2159000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17895000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25709000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
824000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
696000
CY2020Q4 us-gaap Assets
Assets
110378000
CY2019Q4 us-gaap Assets
Assets
147569000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3707000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4152000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9592000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8819000
CY2020Q4 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
4889000
CY2019Q4 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
5960000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11014000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6721000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8621000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7272000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3018000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
25288000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40841000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58212000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1404000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10651000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19230000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
19815000
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
9810000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5045000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5098000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
169316782
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
167987850
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
169000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
168000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1339833000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1329852000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
23000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1305972000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1276228000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34026000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
53815000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110378000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147569000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108621000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59288000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44509000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
895000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
906000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
287000
CY2020 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
60101000
CY2019 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
52885000
CY2018 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
46903000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76598000
CY2018 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
58000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29771000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66847000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70422000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74588000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70002000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
137594000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
128379000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
117192000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-28973000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-69091000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
100646000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70480000
CY2018 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
58000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4732000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
67162000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7759000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109877000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-72683000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
582000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
2532000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
2203000
CY2020 us-gaap Interest Expense
InterestExpense
1353000
CY2019 us-gaap Interest Expense
InterestExpense
335000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29744000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66894000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70480000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
168754000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
167400000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160529000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29744000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66894000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70480000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-27000
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
47000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66894000
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
47000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1576000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9209000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
53815000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29744000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-27000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2596000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7386000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34026000
CY2020 us-gaap Profit Loss
ProfitLoss
-29744000
CY2019 us-gaap Profit Loss
ProfitLoss
-66894000
CY2018 us-gaap Profit Loss
ProfitLoss
-70480000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
128000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-39000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4583000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5673000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1797000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
7297000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9115000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7704000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
706000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
683000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
594000
CY2020 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
122000
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
1073000
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
766000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5862000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6034000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4077000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
126000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
366000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
839000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-68000
CY2020 rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
7814000
CY2019 rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
7118000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-331000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2239000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3755000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
773000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1133000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2893000
CY2020 rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-1071000
CY2019 rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-803000
CY2018 rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
1735000
CY2020 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4051000
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3122000
CY2018 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
269000
CY2020 rigl Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7230000
CY2019 rigl Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6725000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-23629000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
24255000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2437000
CY2019 rigl Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
5098000
CY2018 rigl Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-322000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52185000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41510000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58826000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
81706000
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
145327000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
77996000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
130434000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
123126000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
104066000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1262000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1455000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1106000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47466000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23656000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24964000
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
9975000
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
9789000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2596000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1576000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4732000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
67162000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12571000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11365000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71894000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7852000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-53801000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
38032000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22521000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76322000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38290000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30373000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22521000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76322000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1180000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
137000
CY2020Q4 rigl Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
171000
CY2018Q4 rigl Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
50000
CY2019 rigl Customer Allowance For Prompt Payment Discounts Period Increase
CustomerAllowanceForPromptPaymentDiscountsPeriodIncrease
540000
CY2019 rigl Customer Allowance For Prompt Payment Discounts Period Decrease
CustomerAllowanceForPromptPaymentDiscountsPeriodDecrease
-481000
CY2019Q4 rigl Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
109000
CY2020 rigl Customer Allowance For Prompt Payment Discounts Period Increase
CustomerAllowanceForPromptPaymentDiscountsPeriodIncrease
807000
CY2020 rigl Customer Allowance For Prompt Payment Discounts Period Decrease
CustomerAllowanceForPromptPaymentDiscountsPeriodDecrease
-745000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions made by management include those relating to revenue recognition on product sales and collaboration agreements, recoverability of our assets, including accounts receivables and inventories, stock-based compensation and the probability of achievement of corporate performance-based milestones for our performance-based stock option awards, impairment issues, the weighted average incremental borrowing rate for our lease, estimated interest rate for our financing liability, the estimated useful life of assets, and estimated accruals, particularly research and development accruals, on an ongoing basis. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. To the extent there are material differences between these estimates and actual results, our financial statements will be affected. </p>
CY2020Q4 rigl Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
171000
CY2019Q4 rigl Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
109000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018 rigl Customer Allowance For Prompt Payment Discounts Period Increase
CustomerAllowanceForPromptPaymentDiscountsPeriodIncrease
189000
CY2018 rigl Customer Allowance For Prompt Payment Discounts Period Decrease
CustomerAllowanceForPromptPaymentDiscountsPeriodDecrease
-139000
CY2020 rigl Share Based Compensation Number Of Stock Option Plans
ShareBasedCompensationNumberOfStockOptionPlans
2
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject us to concentrations of credit risk are primarily cash and cash equivalents, short-term investments and accounts receivable. Cash equivalents and short-term investments primarily consist of money market funds, U.S. treasury bills, government-sponsored enterprise securities, and corporate bonds and commercial paper. Due to the short-term nature of these investments, we believe we do not have a material exposure to credit risk arising from our investments. All cash and cash equivalents and short-term investments are maintained with financial institutions that management believes are creditworthy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Concentrations of credit risk with respect to accounts receivable are limited due to our limited number of customers.</p>
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29744000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66894000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70480000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
168754000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
167400000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160529000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108621000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59288000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44509000
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3332000
CY2020 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
13330000
CY2020 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10597000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
6065000
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1636000
CY2019 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
8133000
CY2019 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
6437000
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3332000
CY2020 rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
14800000
CY2020 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
13300000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
6100000
CY2019 rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
9300000
CY2019 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
8100000
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3300000
CY2020 rigl Share Based Compensation Number Of Stock Option Plans
ShareBasedCompensationNumberOfStockOptionPlans
2
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1189000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
810000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
449000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
544000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1638000
CY2019Q4 us-gaap Inventory Net
InventoryNet
1354000
CY2020Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
4000000.0
CY2019Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
3000000.0
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7295000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9115000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7704000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1017000
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
98078000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30373000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22521000
CY2020 rigl Share Based Compensation Arrangement By Share Based Payment Award Options Number Of Homogenous Groups For Determining Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfHomogenousGroupsForDeterminingFairValue
3
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
14218190
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27260463
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
57327000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
26954000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
75557000
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
57327000
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
98078000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
35856000
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
35852000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
87227000
CY2019Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
87250000
CY2020 rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P78D
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
16
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
473000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
23686000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16352000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15204000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13676000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13045000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2676000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2159000
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
86000
CY2019 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
496000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
706000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
683000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
594000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4576000
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3094000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3661000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2836000
CY2020Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
1488000
CY2019Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
238000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
272000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
80000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11014000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6721000
CY2020 rigl Lessee Leasing Arrangements Operating Leases Number Of Renewal Term Periods
LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTermPeriods
2
CY2020Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2014Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
57000
CY2017Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
9328
CY2020Q4 rigl Expected Income From Sublease
ExpectedIncomeFromSublease
9600000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17900000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19300000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y29D
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
5360000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
5248000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
926000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
745000
CY2020 us-gaap Lease Cost
LeaseCost
6286000
CY2019 us-gaap Lease Cost
LeaseCost
5993000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
9694000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
9321000
CY2020 rigl Fixed Sublease Expense
FixedSubleaseExpense
4381000
CY2019 rigl Fixed Sublease Expense
FixedSubleaseExpense
4381000
CY2020 rigl Variable Sublease Expense
VariableSubleaseExpense
962000
CY2019 rigl Variable Sublease Expense
VariableSubleaseExpense
829000
CY2020 us-gaap Sublease Income
SubleaseIncome
5343000
CY2019 us-gaap Sublease Income
SubleaseIncome
5210000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3170000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
240767000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
240157000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
64252000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
315761000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
311658000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10082000
CY2020Q4 rigl Sublease Payments To Be Received Next Twelve Months
SubleasePaymentsToBeReceivedNextTwelveMonths
4534000
CY2020Q4 rigl Lessee Operating Lease Liability Net Payments Next Twelve Months
LesseeOperatingLeaseLiabilityNetPaymentsNextTwelveMonths
5548000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10485000
CY2020Q4 rigl Sublease Payments To Be Received Two Years
SubleasePaymentsToBeReceivedTwoYears
4716000
CY2020Q4 rigl Lessee Operating Lease Liability Net Payments Due Year Two
LesseeOperatingLeaseLiabilityNetPaymentsDueYearTwo
5769000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
877000
CY2020Q4 rigl Sublease Payments To Be Received Three Years
SubleasePaymentsToBeReceivedThreeYears
394000
CY2020Q4 rigl Lessee Operating Lease Liability Net Payments Due Year Three
LesseeOperatingLeaseLiabilityNetPaymentsDueYearThree
483000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21444000
CY2020Q4 rigl Sublease Payments To Be Received
SubleasePaymentsToBeReceived
9644000
CY2020Q4 rigl Lessee Operating Lease Liability Net Payments
LesseeOperatingLeaseLiabilityNetPayments
11800000
CY2020 rigl Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
6300000
CY2019 rigl Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
6000000.0
CY2018 rigl Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
6000000.0
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
67200000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
59603000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
7760000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
8817000
CY2020Q4 rigl Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
4399000
CY2019Q4 rigl Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
6989000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
34000
CY2019Q4 rigl Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
2282000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8358000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7849000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
543000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
509000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8901000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8358000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
543000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
509000
CY2020Q4 rigl Unrecognized Tax Benefits That Would Impact Other Tax Accounts Including Deferred Taxes
UnrecognizedTaxBenefitsThatWouldImpactOtherTaxAccountsIncludingDeferredTaxes
8000000.0
CY2019Q4 rigl Unrecognized Tax Benefits That Would Impact Other Tax Accounts Including Deferred Taxes
UnrecognizedTaxBenefitsThatWouldImpactOtherTaxAccountsIncludingDeferredTaxes
7200000
CY2020Q4 rigl Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
4084000
CY2019Q4 rigl Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
6719000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
537000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
315761000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
311658000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.244
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.217
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.163
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.047
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.028
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.082
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.127
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.051
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.037
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.046
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.015
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4100000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
21600000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168932000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169039000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167173000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167191000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167609000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167619000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168568000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18450000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12624000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10407000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20857000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15400000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1667000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6667000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6667000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4999000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
20000000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55761000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16021000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18389000
CY2020Q1 us-gaap Gross Profit
GrossProfit
12525000
CY2020Q2 us-gaap Gross Profit
GrossProfit
14695000
CY2020Q3 us-gaap Gross Profit
GrossProfit
16149000
CY2020Q4 us-gaap Gross Profit
GrossProfit
17432000
CY2019Q1 us-gaap Gross Profit
GrossProfit
7947000
CY2019Q2 us-gaap Gross Profit
GrossProfit
9862000
CY2019Q3 us-gaap Gross Profit
GrossProfit
11406000
CY2019Q4 us-gaap Gross Profit
GrossProfit
13651000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21243000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17576000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14174000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19237000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17598000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20606000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11490000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17200000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168469000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168570000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168570000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168932000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
169039000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167173000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167191000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167609000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168525000

Files In Submission

Name View Source Status
0001558370-21-002254-index-headers.html Edgar Link pending
0001558370-21-002254-index.html Edgar Link pending
0001558370-21-002254.txt Edgar Link pending
0001558370-21-002254-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rigl-20201231.xsd Edgar Link pending
rigl-20201231x10k.htm Edgar Link pending
rigl-20201231x10k003.jpg Edgar Link pending
rigl-20201231x10k004.jpg Edgar Link pending
rigl-20201231x10k_htm.xml Edgar Link completed
rigl-20201231xex23d1.htm Edgar Link pending
rigl-20201231xex31d1.htm Edgar Link pending
rigl-20201231xex31d2.htm Edgar Link pending
rigl-20201231xex32d1.htm Edgar Link pending
rigl-20201231_cal.xml Edgar Link unprocessable
rigl-20201231_def.xml Edgar Link unprocessable
rigl-20201231_lab.xml Edgar Link unprocessable
rigl-20201231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending